Camille L. Bedrosian, Chief Medical Officer: Amylyx Pharmaceuticals AMLX Sell · Filed 25/04/02

Trade details

Type: Insider sale
Amount: $43,114.75
Shares · price: 12,425 sh · $3.47 a share
Held after: 194,375 sh
Stock: Amylyx Pharmaceuticals AMLX
Person: Camille L. BedrosianChief Medical Officer
Trade date: 25/03/31
Filed: 25/04/02
Days to filing: 2 days

Sold 6.0% of holdings

Share of holding sold: 6.0%

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/03/01~25/04/30

Camille L. Bedrosian's recent trades

Camille L. BedrosianOfficer
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$324.9K
10,028 sh
$324.9K
Filed 09/11
Traded 09/10
Camille L. BedrosianDirector
Planned saleRhythm Pharmaceuticals
Planned sale
Rhythm Pharmaceuticals
RYTM
$5.8M
64,540 sh
$5.8M
Filed 03/04
Traded 03/04
Camille L. BedrosianChief Medical Officer
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$94.2K
6,461 sh
$94.2K
Filed 03/04
Traded 03/02
Camille L. BedrosianDirector
Planned saleRhythm Pharmaceuticals
Planned sale
Rhythm Pharmaceuticals
RYTM
$3.2M
35,460 sh
$3.2M
Filed 03/03
Traded 03/03
Camille L. BedrosianOfficer
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$94.2K
6,461 sh
$94.2K
Filed 03/02
Traded 03/02

Camille L. Bedrosian, Chief Officer — sold $43.1K of Amylyx Pharmaceuticals AMLX · 6.0% of holdings | Whalegun